OncoVenture™ is PCOC's new innovation showcase, highlighting organizations advancing patient-centered oncology care through scalable, evidence-based solutions. Selected companies will present educational case studies and system-level insights to national C- and D-suite oncology leaders, with a focus on improving access, quality, and collaboration across the oncology ecosystem.
This is not a product demo stage.
It is a strategy stage.
Three organizations will be selected to present their innovation at the Patient-Centered Oncology Care® (PCOC) conference.
Why OncoVenture™ Exists
Across oncology, leaders are navigating workforce strain, financial pressures, reimbursement shifts, access disparities, and rapidly evolving care models. Solutions that truly move the needle deserve thoughtful, executive-level visibility.
OncoVenture™ is designed to spotlight innovations that:
Improve patient access, experience, or outcomes
Support operational and financial sustainability
Strengthen collaboration across stakeholders
Deliver measurable, real-world impact
Selected organizations will present during a dedicated 20-minute session at PCOC (15 minutes presentation, 5 minutes audience Q&A).
Application Timeline
Applications Open
April 1
2026
Applications Close
July 1
2026
Selections Announced
August 1
2026
Approved companies will receive formal notification by August 1, providing approximately six weeks to prepare for their presentation at PCOC.
For questions regarding the application process, please contact szyskowski@ajmc.com
Who Should Apply
OncoVenture™ is reserved for organizations with real-world implementation and system-level relevance in U.S. oncology care delivery.
Eligible Company Categories
Health Technology & Digital Innovation
- AI/ML platforms improving oncology workflows, diagnosis, treatment selection, or outcomes
- Data interoperability, real-world evidence, or analytics platforms
- Patient engagement, navigation, or adherence technologies
Care Delivery & Practice Enablement
- Solutions supporting oncology practice operations, staffing, or sustainability
- Care coordination, value-based care, or site-of-care optimization tools
- Tools improving multidisciplinary collaboration across care teams
Access, Equity & Patient Support
- Innovations addressing barriers to care (geography, affordability, health literacy, logistics)
- Tools supporting prior authorization, reimbursement, or financial navigation
- Solutions advancing health equity and underserved populations
Collaboration & Ecosystem Enablement
- Platforms enabling collaboration between providers, payers, pharma, and patients
- Community oncology enablement or network-based care models
Not Eligible
To protect the integrity of the showcase, the following will not be considered:
- • Pure product promotion or sales presentations
- • Single-brand pharmaceutical or device marketing
- • Early-stage concepts without real-world implementation
- • Solutions not relevant to U.S. oncology care delivery
- • Companies unwilling to present educational, non-promotional content
What Selected Organizations Receive
Three organizations will be selected to participate in the OncoVenture™ Innovation Showcase.
Organizations selected to present will be invited to participate for a $15,000 program fee, which includes:
Media Visibility
- Inclusion and coverage of the presentation in AJMC®'s Evidence-Based Oncology® journal
- Digital coverage on AJMC.com
On-Site Presence at PCOC
- 20-minute presentation time block (15-minute presentation + 5-minute Q&A)
- Corporate recognition at the conference
- One 6-foot exhibit table for corporate materials
- Three conference badges
-
◦ Two presenter badges
◦ One additional badge for a company representative
This is executive-level visibility within a highly curated oncology audience.
How Applications Are Reviewed
Applications are reviewed by the AJMC Executive Council, a group of oncology and managed care leaders. Each submission is scored on a scale of 1–5 across six key criteria:
Patient-Centered Impact
Demonstrated improvement in patient access, experience, or outcomes.
Strategic Relevance to Oncology Leadership
Addresses operational, financial, workforce, or quality challenges facing oncology organizations.
Innovation and Differentiation
A novel approach or meaningful advancement in oncology care delivery.
Evidence and Credibility
Real-world implementation, data, or validated outcomes supporting the solution.
Scalability and System-Level Value
Potential to influence oncology care across diverse practice settings.
Educational Value of the Presentation
Ability to deliver actionable insights and learning rather than promotional messaging.